URGN NASDAQ
UroGen Pharma Ltd.
1W: +0.7%
1M: +14.7%
3M: +41.8%
YTD: +31.6%
1Y: +296.3%
3Y: +154.3%
5Y: +96.6%
$28.89
-0.99 (-3.31%)
Weekly Expected Move ±11.5%
$22
$25
$29
$32
$35
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026197
Institutions Holding
+4 vs prior
47.4%
Ownership
-21.96%
29
New
46
Increased
85
Reduced
47
Closed
👔 Insider Trades
16 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-03 | Schoenberg Mark | officer: chief medical officer | S-Sale | 1,844 | $19.69 | $36K | Filing |
| 2026-02-03 | Schoenberg Mark | officer: chief medical officer | S-Sale | 1,843 | $19.69 | $36K | Filing |
| 2026-02-03 | Schoenberg Mark | officer: chief medical officer | S-Sale | 3,686 | $19.69 | $73K | Filing |
| 2026-02-03 | Smith Jason Drew | officer: general counsel | S-Sale | 2,654 | $19.69 | $52K | Filing |
| 2026-02-03 | Smith Jason Drew | officer: general counsel | S-Sale | 1,608 | $19.69 | $32K | Filing |
| 2026-02-03 | Smith Jason Drew | officer: general counsel | S-Sale | 3,217 | $19.69 | $63K | Filing |
| 2025-11-19 | Schoenberg Mark | officer: chief medical officer | S-Sale | 10,000 | $25.00 | $250K | Filing |
| 2025-10-08 | Degnan Chris | officer: chief financial officer | S-Sale | 2,203 | $16.85 | $37K | Filing |
| 2025-09-08 | Schoenberg Mark | officer: chief medical officer | S-Sale | 871 | $19.11 | $17K | Filing |
| 2025-09-08 | Smith Jason Drew | officer: general counsel | S-Sale | 1,520 | $19.11 | $29K | Filing |
| 2025-08-11 | Schoenberg Mark | officer: chief medical officer | S-Sale | 10,000 | $17.69 | $177K | Filing |
| 2025-07-28 | Schoenberg Mark | officer: chief medical officer | M-Option Exercise | 10,000 | $— | $0 | Filing |
| 2025-07-28 | Schoenberg Mark | officer: chief medical officer | S-Sale | 5,149 | $19.14 | $99K | Filing |
| 2025-07-28 | Smith Jason Drew | officer: general counsel | M-Option Exercise | 16,500 | $— | $0 | Filing |
| 2025-07-28 | Smith Jason Drew | officer: general counsel | S-Sale | 7,522 | $19.14 | $144K | Filing |
| 2025-06-09 | Schoenberg Mark | officer: chief medical officer | S-Sale | 5,162 | $7.37 | $38K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 4,543,895 | $82M | — | 2026-03-31 | Filing |
| BlackRock, Inc. | 2,845,567 | $51M | +244,558 | 2026-03-31 | Filing |
| TORONTO DOMINION BANK | 2,616,714 | $47M | +2,616,714 | 2026-03-31 | Filing |
| Kynam Capital Management, LP | 2,247,393 | $40M | +2,247,393 | 2026-03-31 | Filing |
| Jefferies Financial Group Inc. | 2,199,652 | $40M | — | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 1,703,949 | $31M | -2,769,699 | 2026-03-31 | Filing |
| ACORN CAPITAL ADVISORS, LLC | 1,673,420 | $30M | +225,000 | 2026-03-31 | Filing |
| AMERICAN CENTURY COMPANIES INC | 1,637,570 | $29M | +278,758 | 2026-03-31 | Filing |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,503,045 | $27M | -235,776 | 2026-03-31 | Filing |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,314,112 | $24M | +532,492 | 2026-03-31 | Filing |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,152,531 | $21M | — | 2026-03-31 | Filing |
| J. Goldman & Co LP | 938,870 | $17M | +425,567 | 2026-03-31 | Filing |
| ORBIMED ADVISORS LLC | 875,487 | $16M | — | 2026-03-31 | Filing |
| STATE STREET CORP | 874,176 | $16M | +66,755 | 2026-03-31 | Filing |
| Migdal Insurance & Financial Holdings Lt | 770,909 | $14M | — | 2026-03-31 | Filing |
| Soleus Capital Management, L.P. | 727,000 | $13M | +577,000 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 598,528 | $11M | +138,806 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 523,831 | $9M | +48,619 | 2026-03-31 | Filing |
| Woodline Partners LP | 500,726 | $9M | — | 2026-03-31 | Filing |
| Boxer Capital Management, LLC | 500,000 | $9M | — | 2026-03-31 | Filing |